Higher circulating lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. Olpasiran is a small interfering RNA molecule that reduces LP(a). New research findings are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback